Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
12-CdA, 2-chloro-2'-deoxy-beta-D-adenosine
(D00045)		[2] Adenosine,
Cladribine		[2] Adenosine (D00045),
Cladribine 💬 		[5] ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬 		[17] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13 💬
22-CdA, 2-chloro-2'-deoxy-ß-D-adenosine
(D00045)		[2] Adenosine,
Cladribine		[2] Adenosine (D00045),
Cladribine 💬 		[5] ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬 		[17] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13 💬
32-CdA, 2-chloro-2?-deoxy-beta-D-adenosine
(D00045)		[2] Adenosine,
Cladribine		[2] Adenosine (D00045),
Cladribine 💬 		[5] ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬 		[17] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13 💬
42-CdA, 2-chloro-2?-deoxy-ß-D-adenosine
(D00045)		[2] Adenosine,
Cladribine		[2] Adenosine (D00045),
Cladribine 💬 		[5] ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬 		[17] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13 💬
52-CdA, 2-chloro-2’-deoxy-beta-D-adenosine
(D00045)		[2] Adenosine,
Cladribine		[2] Adenosine (D00045),
Cladribine 💬 		[5] ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬 		[17] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13 💬
62-CdA, 2-chloro-2’-deoxy-ß-D-adenosine
(D00045)		[2] Adenosine,
Cladribine		[2] Adenosine (D00045),
Cladribine 💬 		[5] ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬 		[17] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13 💬
72-chloro-2'-deoxy-beta-D-adenosine (2-CdA)
(D00045)		[2] Adenosine,
Cladribine		[2] Adenosine (D00045),
Cladribine 💬 		[5] ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬 		[17] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13 💬
82-chloro-2'-deoxy-ß-D-adenosine (2-CdA)
(D00045)		[2] Adenosine,
Cladribine		[2] Adenosine (D00045),
Cladribine 💬 		[5] ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬 		[17] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13 💬
92-chloro-2?-deoxy-beta-D-adenosine
(D00045)		[1] Adenosine[1] Adenosine (D00045) 💬 [4] ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬 		[13] Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13 💬
102-chloro-2?-deoxy-ß-D-adenosine
(D00045)		[1] Adenosine[1] Adenosine (D00045) 💬 [4] ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬 		[13] Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13 💬
112-chloro-2’-deoxy-beta-D-adenosine
(D00045)		[1] Adenosine[1] Adenosine (D00045) 💬 [4] ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬 		[13] Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13 💬
122-chloro-2’-deoxy-beta-D-adenosine (2-CdA)
(D00045)		[2] Adenosine,
Cladribine		[2] Adenosine (D00045),
Cladribine 💬 		[5] ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬 		[17] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13 💬
132-chloro-2’-deoxy-ß-D-adenosine
(D00045)		[1] Adenosine[1] Adenosine (D00045) 💬 [4] ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬 		[13] Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13 💬
142-chloro-2’-deoxy-ß-D-adenosine (2-CdA)
(D00045)		[2] Adenosine,
Cladribine		[2] Adenosine (D00045),
Cladribine 💬 		[5] ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬 		[17] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13 💬
15Adenosine
(D00045)		[1] Adenosine[1] Adenosine (D00045) 💬 [4] ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬 		[13] Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[4] 13, 57, 58, 65 💬
16Autologous ex vivo gene therapy products based on the EFS LV encoding for the human adenosine deaminase (ADA) gene (EFS-ADA LV)
(D00045)		[1] Adenosine[1] Adenosine (D00045) 💬 [4] ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬 		[13] Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 65 💬